drugset

drugset / Trial / NCT00121069

Study of Escitalopram in the Treatment of Specific Phobia

NCT00121069 ↗

Phase 2/3 Completed 12 enrolled Connor, Kathryn M., M.D. Forest Laboratories · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients.

Timeline

Start: 2002-09
Primary completion: —
Completion: 2004-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Escitalopram	Small molecule	—	—

Indications